Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,740 | 4,290 | -3,490 | -5,190 | -3,320 |
| Depreciation Amortization | 960 | 600 | 1,710 | 1,230 | 600 |
| Other Working Capital | -2,180 | -2,330 | 14,580 | -100 | -1,020 |
| Other Operating Activity | 1,180 | 580 | -580 | -1,240 | -1,130 |
| Operating Cash Flow | $2,700 | $3,140 | $12,220 | $-5,300 | $-4,870 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,530 | -4,030 | -1,920 | -800 | 4 |
| Other Investing Activity | 0 | 0 | 0 | 380 | 0 |
| Investing Cash Flow | $-7,530 | $-4,030 | $-1,920 | $-420 | $4 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 460 | 270 | 74,430 | 11,670 | 700 |
| Financing Cash Flow | $460 | $270 | $74,430 | $11,670 | $700 |
| Exchange Rate Effect | -4,400 | -3,560 | 10,350 | 1,600 | 1,280 |
| Beginning Cash Position | 109,610 | 109,610 | 14,520 | 14,520 | 14,520 |
| End Cash Position | 100,850 | 105,430 | 109,610 | 22,070 | 11,640 |
| Net Cash Flow | $-8,760 | $-4,180 | $95,090 | $7,540 | $-2,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,700 | 3,140 | 12,220 | -5,300 | -4,870 |
| Free Cash Flow | 2,700 | 3,140 | 12,220 | -5,300 | -4,870 |